undamentalytics Newsletter

Abingworth LLP: insider trades

10% owner, Other at 4 companies we cover. 1 open-market purchase and 13 sales not made under a pre-set plan, reported from March 2, 2011 to February 12, 2024.

Would copying Abingworth LLP’s purchases have beaten the S&P 500?

Too few purchases to judge. Only 1 purchase has 12 months of prices after the report; we judge insiders once they have 20. The figures below can swing a long way on a handful of trades. Buying each purchase the day after it was reported, an equal amount each, and holding it 12 months or until they reported a sale would have turned $10,000 on February 13, 2024 into $3,727 by November 2, 2026, −30.6% a year. The copy held shares only 37% of the time, so the fair comparison is the S&P 500 on those same days with Treasury bills otherwise: $13,388, +11.4% a year (the S&P 500 held throughout made $15,812, +18.4% a year). Beta against the index was 0.46. Twelve months after each report, the average purchase was −90.9% against the S&P 500 (median −90.9%), and 0% beat it. Measured from the trade date, the insider’s own timing, the average was −92.0%. After their sales, the shares moved −30.7% against the index over 12 months on average (a negative figure means selling was the right call); 85% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

$0$5.0k$10.0k$15.0k 202420252026 $15.8k$13.4k$3.7k
Copying Abingworth LLPS&P 500, same days investedS&P 500, held throughout $10,000 copying Abingworth LLP’s open-market purchases from February 13, 2024, before costs and taxes, marked weekly. Each purchase gets the same starting stake, bought at the close of the first trading day after the report and sold 12 months later or the day after a reported sale of that stock; uninvested money earns the Treasury bill rate. “Same days invested” holds the S&P 500 only on the days the copy held shares, Treasury bills otherwise.
Return a year, copying
−30.6%
S&P 500, same days invested
+11.4% (held throughout +18.4%)
Time in shares
37%
Sharpe ratio (S&P 500)
−0.31 (0.88)
Biggest drop (S&P 500)
−82% (−19%)
Market sensitivity (beta)
0.46
Purchases copied
1

Trade by trade

Abingworth LLP: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 1 +11.2% +11.2% 100% 1 — — Not enough years
Purchases, 6 months after the report 1 −9.8% −9.8% 0% 1 — — Not enough years
Purchases, 12 months after the report 1 −90.9% −90.9% 0% 1 — — Not enough years
Purchases, 12 months after the trade 1 −92.0% −92.0% 0% 1 — — Not enough years
Sales, 3 months after the report 13 +77.8% +70.5% 8% 4 2.12 0.12 No reliable evidence
Sales, 12 months after the report 13 −30.7% −39.6% 85% 4 −2.18 0.12 No reliable evidence
Sales, 12 months after the trade 13 −30.3% −43.0% 85% 4 −2.34 0.10 No reliable evidence

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Amarin Corp plc\uk AMRN —07March 2, 2011April 19, 2012
Personalis, Inc. PSNL —05August 20, 2020October 21, 2020
Vera Therapeutics, Inc. VERA —01August 19, 2022August 19, 2022
Jasper Therapeutics, Inc. JSPR —10February 12, 2024February 12, 2024

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
February 12, 2024February 8, 2024 JSPR Purchase $2,460,500 +11.2%−90.9%−92.0%
August 19, 2022August 17, 2022 VERA Sale $201,009 −7.1%−11.7%−17.6%
October 21, 2020October 20, 2020 PSNL Sale $3,609,243 +70.5%−59.6%−60.5%
October 20, 2020October 16, 2020 PSNL Sale $7,986,081 +80.7%−55.9%−59.4%
October 16, 2020October 14, 2020 PSNL Sale $2,315,913 +70.5%−62.4%−51.8%
October 14, 2020October 12, 2020 PSNL Sale $5,829,352 +57.5%−54.2%−56.8%
August 20, 2020August 18, 2020 PSNL Sale $18,749,998 +19.1%−53.7%−53.5%
April 19, 2012April 17, 2012 AMRN Sale $38,538,114 +46.3%−54.2%−43.0%
April 5, 2012April 3, 2012 AMRN Sale $25,300,000 +55.4%−39.6%−48.6%
March 15, 2011March 11, 2011 AMRN Sale $20,625,000 +97.8%+10.1%−8.3%
March 10, 2011March 8, 2011 AMRN Sale $4,125,000 +115.0%−8.3%−2.3%
March 8, 2011March 4, 2011 AMRN Sale $760,000 +131.6%−0.9%−6.1%
March 4, 2011March 2, 2011 AMRN Sale $9,240,000 +126.3%−8.6%+7.2%
March 2, 2011February 28, 2011 AMRN Sale $2,558,500 +147.5%+0.4%+7.5%

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Abingworth LLP traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.